Table 5.
Table of median (interquartile range) of urine mark (UM) counts, UM area (in pixels), USV counts, and social investigation (SI, seconds) produced by LHb ‘miss’ and DR ‘miss’ subjects. Male LHb ‘miss’ subjects (n=6) reduced the number of UM (counts, p=0.007) to female stimuli following infusion of V1aR antagonist compared to vehicle injections. Male DR ‘miss’ subjects (n=4) reduced the number of UM (counts, p=0.03) to male stimuli following infusion of V1aR antagonist compared to vehicle injections. Bold numbers represent significant differences between treatment groups.
| treatment | ||||||||
|---|---|---|---|---|---|---|---|---|
| stimulus | ||||||||
| LHb ‘miss’ subjects | ||||||||
| UM (count) | 70 (30–118) | 49 (31–134) |
(p=0.007) 14 (4–85) |
53 (0–112) | 0 (0–0) | 0 (0–16) | 0 (0–112) | 0(0–0) |
| UM (pixels) | 7640 (356019277) | 19871 (53628798) | 12042 (85135031) | 8934 (060452) | 0 (0–0) | 0 (0–3888) | 0 (0–323) | 0(0–0) |
| USV (count) | 463 (187–848) | 24 (9–132) | 400 (7–1256) | 23 (16–58) | 16 (7–70) | 24 (17–25) | 257 (1–398) | 16 (14–21) |
| SI (s) | 37 (25–64) | 23 (13–39) | 56 (26–91) | 16 (11–40) | 20 (17–26) | 8 (5–113) | 18 (12–33) | 13 (5–118) |
| DR ‘miss’ subjects | ||||||||
| UM (count) | 83 (34–118) | 101 (31–136) | 30 (0–179) |
(p=0.03) 28 (0–57) |
0 (0–0) | 0(0–0) | 0(0–0) | 0(0–7) |
| UM (pixels) | 24044 (1238862580) | 18865 (556832421) | 9509 (023348) | 4481 (08962) | 0 (0–0) | 0(0–0) | 0(0–0) | 0 (0–1975) |
| USV (count) | 25 (11–155) | 1 (0–2) | 68 (4–461) | 4 (1–14) | 5 (2–12) | 30 (1–49) | 7 (3–17) | 8 (4–17) |
| SI (s) | 45 (17–89) | 24 (6–36) | 39 (23–66) | 27 (3–30) | 26 (20–34) | 18 (11–25) | 24 (23–26) | 8 (7–19) |